Cutler Group LP Dexcom Inc Call Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	SELL	$112.47 - $130.98 $438,633 - $510,821	-3,900 Reduced 88.64%	500 $2,000
Q1 2023 May 01, 2023	SELL	$104.0 - $122.92 $1.1 Million - $1.3 Million	-10,600 Reduced 70.67%	4,400 $15,000
Q4 2022 Feb 07, 2023	BUY	$84.98 - $122.67 $994,266 - $1.44 Million	11,700 Added 354.55%	15,000 $14,000
Q3 2022 Oct 25, 2022	BUY	$76.35 - $94.18 $221,414 - $273,122	2,900 Added 725.0%	3,300 $3,000
Q2 2022 Aug 04, 2022	SELL	$67.99 - $132.89 $271,960 - $531,560	-4,000 Reduced 90.91%	400 $0
Q3 2021 Oct 26, 2021	BUY	$106.71 - $143.18 $149,394 - $200,452	1,400 Added 46.67%	4,400 $23,000
Q3 2019 Oct 28, 2019	BUY	$35.53 - $43.8 $53,295 - $65,700	1,500 Added 100.0%	3,000 $0
Q1 2019 May 10, 2019	BUY	$28.07 - $38.18 $42,105 - $57,270	1,500 New	1,500 $23,000
Q4 2018 Feb 05, 2019	SELL	$26.99 - $37.37 $67,475 - $93,425	-2,500 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$23.35 - $36.72 $1.2 Million - $1.88 Million	-51,200 Reduced 95.34%	2,500 $7,000
Q3 2017 Oct 17, 2017	BUY	$11.36 - $18.98 $610,032 - $1.02 Million	53,700	53,700 $37,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.